Using toll-like receptor 4 (TLR4)-deficient mice that were lipopolysaccharide (LPS) resistant, we established that organ and tissue inflammation could be induced by serum from SLE patients and lupus-prone mice, but not by LPS contamination (17, 27). Here, TLR4 is linked to systemic lupus erythematosus.